ImmunityBio, Inc. (IBRX)
Nasdaq: IBRX · Biological Products, (No Diagnostic Substances) · San Diego, CA · filing with the SEC since 2005
Who owns ImmunityBio, Inc.
As filed with the SECHolders of 5% or more
1
Patrick Soon-Shiong holds 64.8% of Common Stock, par value $0.0001 per share, as its SCHEDULE 13D/A filed Aug 6, 2026 says.
Directors and officers
11
report now, of 19 people on the record since 2015. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 1 named at left.
Holders of 5% or moreshare of the class, as filed
Patrick Soon-Shiong
SCHEDULE 13D/A · filed Aug 6, 2026 · Common Stock, par value $0.0001 per share · 66.3% in Feb 25, 2026
What IBRX reports owning in othersstakes of 5% or more, and other ties
Other ties the annual report names
NANTibody, LLC
An entity · consolidated entity · owns, named in the 10-K filed Feb 23, 2026
Amyris Joint Venture
An investee · investee · invested in, named in the 10-K filed Feb 23, 2026
Riptide Bioscience, Inc.
An investee · investee · invested in, named in the 10-K filed Feb 23, 2026
Dunkirk Facility
A company bought · asset acquisition · owns, named in the 10-K filed Feb 23, 2026
18 subsidiaries in 4 countries, from the list filed with the 10-K filed Feb 23, 2026.
Insider tradesForm 4
16sales
0purchases
16sales on a scheduled plan
3people selling
$9.5Msold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Oct 6, 2025 to Oct 6, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Oct 6, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window3 of 24 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Simon Barry J. | President and Chief Administrative Officer | 8 | $4.4M | 8 | 0 | $0 |
| Selecky Christobel | director | 6 | $3.0M | 6 | 0 | $0 |
| Cohen Cheryl | director | 2 | $2.1M | 2 | 0 | $0 |